Find participating medical centers and current study status in each of them

    Find participating medical centers

    A clinical trial to compare GDC-9545 plus palbociclib with letrozole plus palbociclib in people with oestrogen receptor-positive, HER2-negative breast cancer

    A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

    • Cancer
    • Breast Cancer
    • Breast Cancer Er-Positive
    • Breast Cancer HER-2 Negative
    • Locally Advanced or Metastatic Breast Cancer